Literature DB >> 26770273

Acquired factor VII deficiency following FOLFOX in a patient with colorectal cancer who was also DPD deficient.

Muhammad Wasif Saif1, Komal Wasif2, Harriette Butler-Bowen3, Kenneth Miller3, Robert B Diasio4.   

Abstract

Entities:  

Year:  2016        PMID： 26770273      PMCID： PMC4699273          DOI： 10.1177/1756283X15604115

Source DB:  PubMed          Journal:  Therap Adv Gastroenterol        ISSN： 1756-283X            Impact factor:   4.409


× No keyword cloud information.
  30 in total

1.  Acquired isolated factor VII deficiency during sepsis.

Authors:  C Biron; C Bengler; J C Gris; J F Schved
Journal:  Haemostasis       Date:  1997 Mar-Apr

2.  A DPYD variant (Y186C) specific to individuals of African descent in a patient with life-threatening 5-FU toxic effects: potential for an individualized medicine approach.

Authors:  M Wasif Saif; Adam M Lee; Steven M Offer; Kathleen McConnell; Valerie Relias; Robert B Diasio
Journal:  Mayo Clin Proc       Date:  2014-01       Impact factor: 7.616

3.  5-fluorouracil-based therapy induces endovascular injury having potential significance to development of clinically overt cardiotoxicity.

Authors:  Søren Astrup Jensen; Jens Benn Sørensen
Journal:  Cancer Chemother Pharmacol       Date:  2011-05-21       Impact factor: 3.333

4.  Life-threatening bleeding in a case of autoantibody-induced factor VII deficiency.

Authors:  K Okajima; M Ishii
Journal:  Int J Hematol       Date:  1999-02       Impact factor: 2.490

5.  Increased prevalence of dihydropyrimidine dehydrogenase deficiency in African-Americans compared with Caucasians.

Authors:  Lori Kay Mattison; Jeanne Fourie; Renee A Desmond; Anil Modak; Muhammad Wasif Saif; Robert B Diasio
Journal:  Clin Cancer Res       Date:  2006-09-15       Impact factor: 12.531

6.  DPYD*2A mutation: the most common mutation associated with DPD deficiency.

Authors:  M W Saif; Hany Ezzeldin; Katisha Vance; Sandra Sellers; Robert B Diasio
Journal:  Cancer Chemother Pharmacol       Date:  2006-12-13       Impact factor: 3.333

7.  Deep-vein thrombosis and the incidence of subsequent symptomatic cancer.

Authors:  P Prandoni; A W Lensing; H R Büller; A Cogo; M H Prins; A M Cattelan; S Cuppini; F Noventa; J W ten Cate
Journal:  N Engl J Med       Date:  1992-10-15       Impact factor: 91.245

8.  Coagulation factor levels in non-metastatic colorectal cancer patients.

Authors:  S Battistelli; M Stefanoni; B Lorenzi; R Dell'avanzato; F Varrone; A Pascucci; R Petrioli; A Vittoria
Journal:  Int J Biol Markers       Date:  2008 Jan-Mar       Impact factor: 2.659

9.  Life-threatening intracranial bleeding associated with the presence of an antifactor VII autoantibody.

Authors:  A Delmer; M H Horellou; G Andreu; T Lecompte; F Rossi; M D Kazatchkine; M Samama; R Zittoun
Journal:  Blood       Date:  1989-07       Impact factor: 22.113

10.  Lupus inhibitors following bone marrow transplant.

Authors:  E W Greeno; R Haake; P McGlave; D Weisdorf; C Verfaillie
Journal:  Bone Marrow Transplant       Date:  1995-02       Impact factor: 5.483
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.